Healthcare


 Avacta (LON: AVCT) Plans Commercial Launch of Lateral Flow Covid-19 Test by Q1

Avacta (LON: AVCT) Plans Commercial Launch of Lateral Flow Covid-19 Test by Q1

February 25, 2021 06:19 AM GMT| By Suhita Poddar

Source: Horth Rasur, Shutterstock Summary Avacta Group is all set to launch its rapid lateral flow Covid test by Q1 2021. The rapid antigen test has been created to spot infectious people for quick isolation. The company would now work toward...

 What are the recent business updates unveiled by LSE listed Clinigen Group?

What are the recent business updates unveiled by LSE listed Clinigen Group?

February 24, 2021 02:42 PM GMT| By Team Kalkine Media

Source: Shutterstock Summary Clinigen Group PLC had reported an increase of 4% in net organic revenue during H1 FY21 ended 31 December 2020. CLIN had announced an interim dividend of 2.15 pence per share for H1 FY21. Sam Herbert was appointed.....

 Will AstraZeneca meet its EU delivery targets for the second quarter? 

Will AstraZeneca meet its EU delivery targets for the second quarter? 

February 24, 2021 02:21 PM GMT| By Team Kalkine Media

  AstraZeneca PLC (LON: AZN) has expressed its disability to deliver the agreed doses of the Covid-19 vaccine to the European Union, but promised to increase the productivity to meet the demand of 180 million doses. An EU official&n.....

 How effective is the Pfizer-BioNtech vaccine against the South African coronavirus strain? 

How effective is the Pfizer-BioNtech vaccine against the South African coronavirus strain? 

February 18, 2021 11:55 AM GMT| By Team Kalkine Media

Summary A lab study has found that Pfizer-BioNtech vaccine could be less impactful on South African strain. The vaccine had two-thirds less neutralising impact on antibodies against the South African strain. Though the companies.....

 How Kanabo will gain from its smashing debut at London Stock Exchange

How Kanabo will gain from its smashing debut at London Stock Exchange

February 17, 2021 12:11 PM GMT| By Hina Chowdhary

Summary Kanabo came up with an IPO on 16 February which was worth 4.75 pence per share. The shares quadrupled in value at the closing of the first day of trading. Medical marijuana firm Kanabo, also called Nes.....

 What Led to A Surge in Astrazeneca’s Product Sales In 2020?

What Led to A Surge in Astrazeneca’s Product Sales In 2020?

February 11, 2021 02:41 PM GMT| By Team Kalkine Media

Summary The pharma company announced that its Q4 2020 sales had jumped by 12 per cent to just over $7 billion. The company said it could take about six to nine months to make new vaccines protecting against new strains of the Covid-19 virus. T.....

 Dechra Pharma wins licence to sell Tri-Solfen in Australia, NZ 

Dechra Pharma wins licence to sell Tri-Solfen in Australia, NZ 

February 09, 2021 02:20 PM GMT| By Hina Chowdhary

Summary Dechra Pharmaceuticals announced it had secured the right to sell animal pain management product Tri-Solfen in Australia and New Zealand markets. The pharma company can now market the cattle drug worldwide The Londo.....

 Covid-19: Van-Tan Assures Usage of Astrazeneca Vaccine Safe for Brits

Covid-19: Van-Tan Assures Usage of Astrazeneca Vaccine Safe for Brits

February 09, 2021 10:25 AM GMT| By Team Kalkine Media

Summary At a press conference at the Downing Street on Monday, Professor Jonathan Van-Tan reassured Brits that they were safe after South Africa suspended AstraZeneca’s vaccine rollout. A recent study has highlighted that AstraZeneca-Oxfo.....

 Active Biotech and Famar Health Care sign a manufacturing deal 

Active Biotech and Famar Health Care sign a manufacturing deal 

February 07, 2021 12:45 AM GMT| By Hina Chowdhary

Summary Both the healthcare sector companies have signed a contract on Thursday, 4 February. Under the agreement, Famar Health will be providing Active Biotech with clinical trial material.  &nb.....

 Astrazeneca’s Covid-19 Vaccine Efficient for Elders, Says UK Regulators

Astrazeneca’s Covid-19 Vaccine Efficient for Elders, Says UK Regulators

February 06, 2021 12:23 AM GMT| By Kunal Sawhney

Summary The British-Swedish pharma major has come up with extra trial data which shows that vaccine is effective in the elderly group Some of the European nations have been doubting whether the vaccine is effective on elderly age group or not .....

 Sensyne Health Unveils AI Algorithm for Real-Time Hospital Management 

Sensyne Health Unveils AI Algorithm for Real-Time Hospital Management 

February 05, 2021 02:07 PM GMT| By Hina Chowdhary

Summary Sensyne Health unveiled its first operational artificial intelligence algorithm SYNE-OPS-1 The SYNE-OPS-1 provides real-time operational decision-making support to healthcare managers.  The company's CEO Lord Drayson plans to.....

 Jazz Pharmaceuticals acquires GW Pharmaceuticals for £5.3 billion

Jazz Pharmaceuticals acquires GW Pharmaceuticals for £5.3 billion

February 04, 2021 01:58 PM GMT| By Hina Chowdhary

Summary GW Pharmaceuticals has announced that Ireland’s Jazz Pharmaceuticals will be buying it out for £3 billion in a cash and stock deal.  The deal is likely to close by the second quarter of this year. GW’s drug .....

 McKinsey agrees to $573mn multi-state opioid settlement 

McKinsey agrees to $573mn multi-state opioid settlement 

February 04, 2021 11:20 AM GMT| By Kunal Sawhney

Summary McKinsey has agreed to a multi-state settlement claim of at least US $573 million for its sales and marketing advice to Oxycontin maker Purdue Pharma. McKinsey’s settlement claims are with 43 states, the District of Columbia and t.....

 AstraZeneca Oxford vaccine could lead to fall in coronavirus spread, claims study

AstraZeneca Oxford vaccine could lead to fall in coronavirus spread, claims study

February 03, 2021 07:30 AM GMT| By Team Kalkine Media

Summary A scientific study suggests that a single dose of the AstraZeneca Oxford vaccine lowers the Covid-19 virus transmission by two-third. A single shot offers 76 per cent immunity against the virus for up to a period of three months. A.....

 Moderna Inc (NASDAQ: MRNA) initiates additional filling of vials containing Covid-19 vaccine 

Moderna Inc (NASDAQ: MRNA) initiates additional filling of vials containing Covid-19 vaccine 

February 02, 2021 07:54 AM GMT| By Team Kalkine Media

Summary The pharma company has proposed increasing of filling vials by up to five additional doses. The US FDA had initially purchased 200 million doses of Moderna vaccine, following which it ordered additional 100 million jabs. .....

 Valneva shares jump 16% after UK government decides to procure 40 mn more vaccine doses

Valneva shares jump 16% after UK government decides to procure 40 mn more vaccine doses

February 01, 2021 12:49 PM GMT| By Kunal Sawhney

Summary Shares of Valneva jumped 16 per cent after the UK government procured 40 million additional doses of its Covid-19 vaccine. After the jump, the shares of Valneva SE hit a fresh all-time high on the .....

 UK May Get Its Fourth Covid-19 Vaccine, Novavax Shows High Efficacy in Phase III Trials

UK May Get Its Fourth Covid-19 Vaccine, Novavax Shows High Efficacy in Phase III Trials

January 31, 2021 12:01 AM GMT| By Team Kalkine Media

Summary                  The new Novavax vaccine has an 86 per cent efficacy against the coronavirus. Novavax will be produced in association with Teesside University in England. The UK has sought 60...

 Siemens Healthineers partners with British hospital trust MFT 

Siemens Healthineers partners with British hospital trust MFT 

January 28, 2021 01:24 PM GMT| By Hina Chowdhary

Summary A 15-year long contract has been signed by both the parties for a financial consideration of EUR 140 million.  Under the agreement, Siemens will provide MFT with an installation of 350 medical equipment. Germany-based&nbs.....

 J&J’s (NYSE: JNJ) Former Talc Supplier Intends to File for Bankruptcy

J&J’s (NYSE: JNJ) Former Talc Supplier Intends to File for Bankruptcy

January 13, 2021 10:34 AM GMT| By Kunal Sawhney

Summary Imerys Talc America talc supplier of J&J is seeking bankruptcy to evade mass litigation matters J&J is awaiting phase 3 trial of its Covid-19 vaccine shortly, which would help in determining the efficacy and safety of the vaccin.....

 What are the recent developments announced by Tiziana Life Sciences on its Covid-19 vaccine clinical trial?

What are the recent developments announced by Tiziana Life Sciences on its Covid-19 vaccine clinical trial?

January 11, 2021 04:31 PM GMT| By Hina Chowdhary

Summary Tiziana Life Sciences had not reported any revenue since its inception. The Company had announced the completion of its clinical study in Brazil investigating nasally administered Foralumab. The Company had completed the demerger of St.....

Recent Articles






Investing Tips

Previous Next